| Secondary |
| Hiv Infection |
41.1% |
| Product Used For Unknown Indication |
19.6% |
| Antiviral Prophylaxis |
10.4% |
| Drug Use For Unknown Indication |
9.8% |
| Prophylaxis |
5.1% |
| Antifungal Prophylaxis |
2.1% |
| Plasma Cell Myeloma |
1.8% |
| Drug Exposure During Pregnancy |
1.5% |
| Pneumocystis Jiroveci Pneumonia |
1.2% |
| Chest Discomfort |
1.0% |
| Hiv Test Positive |
1.0% |
| Respiratory Tract Infection |
0.9% |
| Antibiotic Therapy |
0.6% |
| Atrial Fibrillation |
0.6% |
| Diarrhoea |
0.6% |
| Liver Transplant |
0.6% |
| Mycobacterium Abscessus Infection |
0.6% |
| Pain In Extremity |
0.6% |
| Renal Transplant |
0.6% |
| Depression |
0.4% |
|
| Osteonecrosis |
16.0% |
| Pregnancy |
11.7% |
| Death Neonatal |
8.5% |
| Drug Exposure During Pregnancy |
8.5% |
| Toxic Epidermal Necrolysis |
5.3% |
| Vomiting |
5.3% |
| White Blood Cell Count Increased |
5.3% |
| Pancytopenia |
4.3% |
| Rash |
4.3% |
| Death |
3.2% |
| Hepatitis |
3.2% |
| Malnutrition |
3.2% |
| Maternal Drugs Affecting Foetus |
3.2% |
| Neutrophil Count Decreased |
3.2% |
| Rash Maculo-papular |
3.2% |
| Renal Failure Acute |
3.2% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
2.1% |
| Peripheral Sensorimotor Neuropathy |
2.1% |
| Rhabdomyolysis |
2.1% |
| Sciatica |
2.1% |
|
| Concomitant |
| Hiv Infection |
31.0% |
| Drug Use For Unknown Indication |
13.9% |
| Product Used For Unknown Indication |
10.5% |
| Prophylaxis |
10.5% |
| Hiv Test Positive |
3.9% |
| Renal Transplant |
3.6% |
| Antifungal Prophylaxis |
3.0% |
| Infection Prophylaxis |
2.5% |
| Prophylaxis Of Nausea And Vomiting |
2.4% |
| Pneumocystis Jiroveci Pneumonia |
2.2% |
| Prophylaxis Against Transplant Rejection |
2.0% |
| Hypertension |
1.8% |
| Chemotherapy |
1.7% |
| Pneumonia |
1.7% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.6% |
| Diffuse Large B-cell Lymphoma |
1.6% |
| Chronic Lymphocytic Leukaemia |
1.5% |
| Vitamin Supplementation |
1.5% |
| B-cell Lymphoma |
1.5% |
| Pain In Extremity |
1.5% |
|
| Vomiting |
18.1% |
| Weight Decreased |
10.2% |
| Pyrexia |
9.8% |
| Sepsis |
9.8% |
| Septic Shock |
4.7% |
| Myositis |
4.2% |
| Toxic Epidermal Necrolysis |
4.2% |
| Febrile Neutropenia |
3.7% |
| Renal Failure Acute |
3.3% |
| Suicide Attempt |
3.3% |
| Tachycardia |
3.3% |
| Urinary Tract Infection |
3.3% |
| Hepatotoxicity |
2.8% |
| Pain In Extremity |
2.8% |
| Pneumonia Bacterial |
2.8% |
| Renal Impairment |
2.8% |
| Respiratory Distress |
2.8% |
| Respiratory Failure |
2.8% |
| Tachypnoea |
2.8% |
| Thrombocytopenia |
2.8% |
|
| Interacting |
| Product Used For Unknown Indication |
63.6% |
| Hiv Infection |
31.8% |
| Fungal Infection |
4.5% |
|
| Haemolytic Uraemic Syndrome |
25.0% |
| Rash |
25.0% |
| Respiratory Failure |
25.0% |
| White Blood Cell Count Increased |
25.0% |
|
